Atlas Trials

Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia

Clinical trial NCT03520049 · UNKNOWN

Trial details

NCT number
NCT03520049
Sponsor
Unity Health Toronto
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Immune Thrombocytopenia
Start date
2016-11-01
Primary completion
2021-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.